Cannabinoid effects on sustained conductances that control neuronal excitability have not been investigated in brain. Here, intracellular voltage-clamp recordings were performed using the rat hippocampal slice preparation to study the postsynaptic effect of cannabinoid agonists on CA1 pyramidal neurons. Superfusion of the cannabimimetics WIN55212-2 or methanandamide onto CA1 neurons elicited an inward steady-state current that reversed near the equilibrium potential for K ϩ and voltage-dependently activated from a threshold of approximately Ϫ70 mV. The cannabinoid receptor (CB1) antagonist SR141716 did not alter membrane properties but prevented this effect. Further investigation revealed that the inward current elicited by cannabinoids was caused by a decrease of the noninactivating voltage-dependent K ϩ M-current (I M ). Cannabinoids had no effect in slices pretreated with the M-channel blocker linopirdine. Assessment of the I M relaxation indicated that cannabinoids decreased I M in a concentration-dependent manner, with a maximum inhibition of 45 Ϯ 3% with WIN55212-2 (EC 50 of 0.6 M) and 41 Ϯ 5% with methanandamide (EC 50 of 1 M). Cannabinoids did not affect the inwardly rectifying cationic h-current (I h ). The cannabinoid-induced I M decrease was prevented by SR141716 but remained unaffected by the muscarinic receptor antagonist atropine. Conversely, the cholinergic agonist carbamylcholine decreased I M in the presence of SR141716, indicating that cannabinoid and muscarinic receptor activation independently diminish I M . It is concluded that cannabinoids may postsynaptically augment the excitability of CA1 pyramidal neurons by specifically decreasing the persistent voltage-dependent I M .
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Cannabinoid substances have powerf ul psychoactive properties and alter many physiological processes, such as cognition, behavior, and nociception (Ameri, 1999) . These effects are believed to be mediated via specific high-affinity binding sites present throughout the brain (Herkenham et al., 1990) . A G-proteinlinked receptor expressed in brain (CB1) has been cloned (Matsuda et al., 1990) , and the compound SR141716 (SR1) is a selective antagonist at this receptor (Rinaldi-C armona et al., 1994) . One of the highest CB1 receptor density is found in the hippocampus, a brain structure associated with learning and memory processes, and cannabinoids appear to impair memory via activation of these receptors (Lichtman and Martin, 1996) . The discovery of specific receptors led to the isolation of two endogenous ligands, the endocannabinoids anandamide (Devane et al., 1992) and 2-arachidonylglycerol (Mechoulam et al., 1995) , both found in brain (Di Marzo et al., 1994; Stella et al., 1997) .
Little is known on the cellular mechanisms underlying the central effects of cannabinoids, and only a few studies have been conducted at the postsynaptic level. In cultured hippocampal neurons, cannabinoid agonists increase the transient K ϩ A-current (I A ) (Deadw yler et al., 1993) and reduce currents passing through N-and P/Q type calcium channels (T witchell et al., 1997; Shen and Thayer, 1998) . C annabinoids receptors heterologously expressed in ganglion neurons also reduce Ca 2ϩ currents without altering the K ϩ A-and M-currents (Pan et al., 1996) . Other studies using coexpression or transfection of CB1 receptors in non-neuronal systems showed that cannabinoids may also activate an inwardly rectifying K ϩ conductance (Henry and Chavkin, 1995; Mackie et al., 1995) . No postsynaptic studies, however, have investigated the effect of cannabinoids on sustained (noninactivating) conductances in native brain preparations, such as the hippocampal slice.
Hippocampal neurons are under the tonic control of sustained conductances, such as I M , I h , and leak-currents, which are active at or near resting potential and readily regulate neuronal activity (Storm, 1990) . The time-and voltage-dependent I M is modulated by several neurotransmitters and plays a unique role in modulating cellular excitability, because it is the only K ϩ current that both activates below the action potential threshold and does not inactivate (Brown and Adams, 1980; Marrion, 1997) . In CA1 pyramidal neurons, I M is decreased by muscarinic agonists and serotonin (Halliwell and Adams, 1982; Colino and Halliwell, 1987) and increased by somatostatin (Moore et al., 1988) . Because I M opposes membrane depolarization, substances that decrease this current augment neuronal excitability, whereas substances that increase I M diminish neuronal excitability.
Although sustained conductances are modulated by numerous neurotransmitters, their sensitivity to cannabinoids has not been investigated in brain. Previous postsynaptic studies have been conducted with cultured neurons or non-neuronal cells. In the present study, I recorded from native neurons in a slice preparation and found that cannabinoids reduce the K ϩ I M via activation of CB1 receptors, thus postsynaptically augmenting neuronal excitability.
MATERIALS AND METHODS
Slice preparation. Standard intracellular recording techniques were used in rat hippocampal slices as described previously (Schweitzer et al., 1993) . In brief, transverse hippocampal slices (taken from male Sprague Dawley rats of 100 -170 gm) 350-m-thick were cut on a slicer and incubated in gassed (95% O 2 , 5% CO 2 ) artificial C SF (AC SF) of the following composition (in mM): NaC l 130, KC l 3.5, NaH 2 PO 4 1.25, MgSO 4 1.5, C aC l 2 2.0, NaHC O 3 24, and glucose 10. Slices were completely submerged and continuously superf used with warm (30 -31°C) AC SF at a constant rate within the range of 1-3 ml /min. Methods of superf usion, voltage-clamp recording, drug administration, and data analysis were as described previously (Schweitzer et al., 1993) . Drugs were added to the AC SF with dimethylsulfoxide (0.05-0.15% final concentration). Dimethylsulfoxide did not affect membrane properties at this concentration (Schweitzer et al., 1993) . R1-methanandamide, W I N55212-2, and linopirdine (DuP 996) were purchased from Research Biochemicals (Natick, M A), tetrodotoxin was from C albiochem (La Jolla, CA), and all other chemicals were from Sigma (St. L ouis, MO). SR141716 was obtained from the National Institute of Mental Health Chemical Synthesis and Drug Supply Program.
Voltage-clamp recordings. Voltage-clamp studies were performed with an Axoclamp 2A preamplifier (Axon Instruments, Foster C ity, CA), using sharp glass micropipettes filled with 3 M KC l (impedance range of 50 -85 M⍀) to penetrate CA1 pyramidal neurons. Tetrodotoxin (1 M) was added to the bath after impalement to block Na ϩ -dependent action potentials and synaptic transmission. In discontinuous single-electrode voltage-clamp mode, the switching frequency between current injection and voltage sampling was 3-4 kHz. Current and voltage records were filtered at 0.3 kHz, acquired by analog-to-digital sampling and acquisition software, and measured with analysis software (Axon Instruments). Values are presented as mean Ϯ SEM. The various problems associated with voltage-clamping of neurons with extended processes were discussed previously (Halliwell and Adams, 1982; Johnston and Brown, 1983) . Such problems should be minimized when studying relative conductance changes with superf usion of drugs to equilibrium conditions.
Voltage protocols. Current-voltage ( I-V) curves were generated by holding neurons at Ϫ59 Ϯ 0.2 mV (n ϭ 47) and applying hyperpolarizing and depolarizing voltage steps (1.5 sec duration, 7 sec apart). Neurons were not depolarized beyond Ϫ40 mV because of space-clamp considerations and the likelihood of activating large C a 2ϩ currents. I-V curves were constructed from current values measured at the end of the voltage step (steady state), and the values obtained in control condition were subtracted from those in presence of the tested substances to obtain the net current induced. T wo voltage-dependent noninactivating conductances found in CA1 neurons were separately assessed. The I M relaxation was observed at the onset of hyperpolarizing voltage steps (1 sec duration) delivered from a holding potential (V H ) of Ϫ44 Ϯ 0.3 mV (n ϭ 49). The I h relaxation was observed at the onset of hyperpolarizing voltage steps delivered from a holding potential of Ϫ59 mV (Halliwell and Adams, 1982) .
RESULTS
Intracellular recordings were performed from 65 CA1 pyramidal neurons using the adult hippocampal slice preparation to investigate cannabinoid effects on sustained conductances. The average resting membrane potential (RM P) was Ϫ69 Ϯ 0.3 mV, the input resistance determined at onset of a small hyperpolarizing current step before addition of tetrodotoxin was 74 Ϯ 2 M⍀, and the action potential amplitude from threshold was 104 Ϯ 1 mV. Two nondegradable cannabinoid agonists were used: the methylated analog of anandamide R1-methanandamide (mAEA), and the aminoalkyndole W I N55212-2 (W I N-2).
Cannabinoids elicit an inward steady-state current
I-V relationships were generated to study the effects of cannabinoids on steady-state membrane properties in the depolarized and hyperpolarized ranges. Superf usion of mAEA (5 M) onto CA1 pyramidal neurons elicited an inward steady-state current in the depolarized range but showed no effect at hyperpolarized potentials ( Fig. 1 A) . Current values were back near control upon washout of the drug. The net steady-state currents were obtained by subtracting current values obtained at each condition from current values in control (Fig. 1 B) . The mAEA component showed voltage-dependence and had a reversal potential of Ϫ87 Ϯ 5 mV (n ϭ 5), close to the theoretical equilibrium potential for K ϩ (Ϫ98 mV in these experimental conditions). The conductance decrease elicited by mAEA, G mAEA , was calculated by dividing the cannabinoid-induced current by the driving force (Fig. 1C) . G mAEA was voltage-dependent with an activation threshold of approximately Ϫ75 mV and amplitude of Ϫ3.1 nS at Ϫ43 mV. The mAEA effect was dose-dependent as the amplitude of the inward current increased with the drug concentration (Fig.  2) . The apparent threshold response was 0.25 M, and the maximum effect was obtained with 5 M mAEA. pyramidal neuron held at Ϫ56 mV was subjected to three different voltage steps sequentially applied and superimposed at each condition (voltage protocol at bottom lef t). Superf usion of 5 M mAEA induced an inward steady-state current at depolarized potentials (170 pA at Ϫ42 mV) but had no effect in the hyperpolarized range. RM P was Ϫ69 mV. B, Net currents averaged from five neurons exposed to 5 M mAEA. The cannabinoid elicited a voltage-dependent inward current that reversed at Ϫ87 mV, with recovery to control values on washout of the drug. C, Plot of the mAEA-induced conductance derived from B. G mAEA was calculated as I mAEA /(V Ϫ V rev ), where I mAEA is the mAEA-induced current, V is the command potential, and V rev is the reversal potential. The conductance was voltage-dependent and activated at approximately Ϫ75 mV.
It was then determined whether the mAEA effect was mediated via activation of CB1 receptors by using the selective CB1 receptor antagonist SR1. Superf usion of SR1 alone (1 M) did not elicit a measurable effect on steady-state currents throughout the potential range tested (Fig. 3 A, B) . However, the mAEA-induced component was completely prevented by SR1, indicating that the cannabinoid effect occurred via activation of CB1 receptors. To confirm these findings, the experiments were repeated with the structurally different cannabinoid W I N-2. W I N-2 had effects similar to those of mAEA and induced a voltage-dependent inward current that reversed at Ϫ85 mV (Fig. 3C) . The threshold response was 0.25 M and the maximum inward current was obtained with 2 M (n ϭ 6), because superf usion of 5 M WIN-2 did not elicit a larger effect (n ϭ 3; data not shown). The maximum effect, however, was not as pronounced and consistent as the effect observed with mAEA, although it occurred at a lesser concentration. The effect of W I N-2 was also prevented by SR1 (Fig. 3C ), demonstrating involvement of CB1 receptors.
Cannabinoids decrease I M
The I M is a persistent voltage-dependent K ϩ outward current that activates at approximately Ϫ70 mV, thus having properties resembling the effect elicited by cannabinoids. A separate voltage protocol was used to quantif y I M (see Materials and Methods) and determine whether cannabinoids decreased I M to elicit the observed inward steady-state current at depolarized potentials. Addition of W I N-2 in the superf usate indeed reduced I M relaxation amplitudes (Fig. 4 A) and concomitantly elicited an inward holding current (Fig. 4 A, dotted line) , consistent with closing of M-channels. All values returned toward control levels upon washout of W I N-2, although recovery was only partial. The averaged effect on I M over nine neurons is shown on Figure 4 B; WIN-2 (2-5 M) decreased I M to 55 Ϯ 3% of control, with a recovery on washout to 85 Ϯ 6% of control. The specific I M blocker linopirdine (Aiken et al., 1995) was used to f urther identif y I M as the target of the cannabinoid effect. Linopirdine elicited an inward steady-state current because of I M inhibition (Fig. 4C ) and decreased I M relaxations to 18 Ϯ 4% of control (n ϭ 5; data not shown). Addition of 2 M WIN-2 in the continued presence of linopirdine did not alter steady-state currents (Fig. 4C) or I M relaxations that remained at 17 Ϯ 4% of control, indicating that cannabinoids solely affected I M .
Cannabinoids reportedly augment inwardly rectifying K ϩ conductances in expression systems. I investigated a possible action of cannabinoids on I h (also called I Q ), a persistent Na ϩ -K ϩ conductance that activates in the hyperpolarized range below Ϫ60 mV and rectifies inwardly. The I h relaxation amplitude was unchanged upon exposure to mAEA (Fig. 4 D) or WIN-2 (data not shown). On average, I h remained at 99 Ϯ 3% of control when neurons were exposed to 5-10 M mAEA (n ϭ 6) and 101 Ϯ 2% of control when 2-5 M WIN-2 was applied (n ϭ 8).
The cannabinoid-induced I M decrease was concentrationdependent. Superfusion of 1 M mAEA decreased the I M ampli- . The cannabinoid inward current is elicited via activation of CB1 receptors. A, Selected current traces from a neuron exposed to the CB1 antagonist SR1 (1 M) and mAEA (5 M) in the presence of SR1. SR1 alone had no effect but completely prevented the mAEA response. RM P was Ϫ67 mV, and V H was Ϫ59 mV. B, Net currents averaged from seven neurons exposed to 1 M SR1 alone and three neurons exposed to 5-10 M mAEA in the presence of SR1. The antagonist completely prevented the mAEA effect. C, Net currents elicited by WIN-2 in the absence (2 M; n ϭ 6) or presence (2-5 M; n ϭ 5) of 1 M SR1. WIN-2 elicited a voltage-dependent inward current that was completely prevented by SR1.
tude by 27% and elicited a small inward holding current (Fig. 5A) . A higher concentration of 5 M mAEA elicited a stronger effect to decrease I M by 58%, concomitant with a large inward holding current (Fig. 5B) . Current values returned near control levels on washout of mAEA. The dose -response relationship obtained with W I N-2 and mAEA is shown in Figure 5C . W I N-2 had a maximal effect at 3 M to decrease I M to 55% of control, with an apparent EC 50 of 0.6 M. The maximal effect with mAEA was obtained at 6 M to decrease I M to 59% of control, with an apparent EC 50 of 1 M.
Cannabinoids decrease I M via CB1 receptors independently of muscarinic receptors
The CB1 receptor antagonist SR1 was used to determine whether the cannabinoid-induced I M decrease occurred via activation of CB1 receptors. Superf usion of 1 M SR1 alone had no effect on I M amplitude (n ϭ 5; data not shown). In the presence of SR1, however, a subsequent application of W I N-2 at concentrations that greatly reduced I M (1-5 M; n ϭ 5) was without effect (Fig.  6 A, B) . Likewise, mAEA (5-10 M; n ϭ 3) did not affect I M nor elicit an inward holding current in slices pretreated with SR1 (Fig.  6C) , indicating that cannabinoids decreased I M by activating CB1 receptors.
A possible involvement of muscarinic receptors in the cannabinoid effect was investigated by treating the slices with the muscarinic receptor antagonist atropine. In the presence of 1 M atropine, the nondegradable cholinergic agonist carbamylcholine (carbachol, 5 M) did not affect I M because of blockade of muscarinic receptors. Addition of 2 M WIN-2 in the presence of atropine, however, greatly decreased the I M relaxation (Fig. 7A) . On average, atropine alone did not affect I M , but addition of WIN-2 together with atropine decreased I M to 56 Ϯ 5% of control (n ϭ 5) (Fig. 7B) , a value similar to that observed in the absence of the muscarinic antagonist (55 Ϯ 3% of control) (Fig.  4 B) . To ensure that the well known muscarinic-induced I M inhibition occurred independently of CB1 receptors, additional experiments were conducted with SR1 and carbachol. In the presence of the cannabinoid receptor antagonist, WIN-2 no longer altered I M , but further addition of 5 M carbachol greatly decreased I M (Fig. 7C) . On average, carbachol was more efficacious than cannabinoids and decreased I M to 20 Ϯ 6% of control (n ϭ 4; 15 mV hyperpolarizing step). These results show that cannabinoid and muscarinic receptor agonists independently diminish I M .
The cannabinoid effects on the I M relaxation are summarized for comparison in Figure 8 . WIN-2 decreased I M by 45 Ϯ 3% when applied alone and by 44 Ϯ 5% in the presence of atropine. SR1 alone did not affect I M (2 Ϯ 3% increase) but prevented WIN-2 from inhibiting I M (3 Ϯ 5% decrease). Similar to WIN-2, mAEA decreased I M by 41 Ϯ 5% in absence of SR1 and by 6 Ϯ 6% when the CB1 receptor antagonist was present. 
DISCUSSION
The results showed that cannabinoids acting at CB1 receptors elicited a postsynaptic excitatory effect on CA1 pyramidal neurons by decreasing the persistent voltage-dependent I M .
Cannabinoids decrease the persistent I M
In the presence of tetrodotoxin to block neurotransmission, cannabinoids elicited an inward current that voltage-dependently increased with depolarization. The current reversed at Ϫ87 mV, indicating that K ϩ was the carrier, and activated at approximately Ϫ75 mV. Such properties were reminiscent of I M , a time-and voltage-dependent persistent K ϩ current that activates between Ϫ80 and Ϫ70 mV, and the I-V relationship profile of the cannabinoid effect was consistent with a decrease of I M . Although the inwardly rectif ying I h activates only at hyperpolarized potentials, the I M and I h relaxations appear similar. The results showed that neither WIN-2 nor mAEA altered I h . Moreover, WIN-2 had no effect on neurons pretreated with the M-channel blocker linopirdine (Aiken et al., 1995) , verifying that cannabinoids solely affected I M . However, I-V relationships were not performed beyond Ϫ40 mV because of space-clamp considerations, and a cannabinoid action on conductances active at more depolarized potentials is possible.
The cannabinoid effect was dose-dependent. WIN-2 and mAEA had a comparable efficacy and decreased I M to a similar level, although WIN-2 appeared more potent. The EC 50 values of 0.6 and 1 M are comparable with the 1-2 M range reported for synaptic inhibition in brain slices (Lévénès et al., 1998; Szabo et al., 1998) but much higher than the 10 -20 nM range reported for Ca 2ϩ current inhibition in hippocampal cultures (Twitchell et al., 1997; Shen and Thayer, 1998) . Such discrepancy is usually attributed to limited drug penetration and inferior access to the recorded neurons in slice preparations. After washout of W I N-2 coincident with superf usion of 1 M SR1, a second application of W I N-2 in the continued presence of SR1 had no effect on I M . The bottom panel shows the magnified I M relaxations. RMP was Ϫ71 mV. B, Average of I M amplitude on five neurons exposed to 1-5 M W I N-2 in slices treated with 1 M SR1, showing the lack of effect of the cannabinoid in presence of the CB1 antagonist. C, SR1 also prevented the I M decrease expected with superf usion of 5 M mAEA. RMP was Ϫ67 mV, and V H was Ϫ48 mV.
Cannabinoid and muscarinic receptor activation independently decrease I M
The inward steady-state current and I M decrease elicited by mAEA and W I N-2 were both prevented in slices treated with SR1, demonstrating that cannabinoids activated CB1 receptors. A previous report showed that endocannabinoids are detected in hippocampal slices subjected to similar experimental conditions, including the presence of tetrodotoxin (Stella et al., 1997) . In the present study, SR1 applied alone had no effect on the recorded currents, indicating that endocannabinoids may not tonically affect postsynaptic properties in the slice preparation.
Cholinergic agonists acting at muscarinic receptors decrease I M . Because cannabinoids have been shown to inhibit the release of acetylcholine in hippocampus (Gifford and Ashby, 1996) and carbachol reportedly enhances the production of the endocannabinoid 2-arachidonylglycerol in rat aorta (Mechoulam et al., 1998b) , experiments using receptor antagonists were conducted to investigate possible interactions. The presence of atropine did not alter the extent of I M inhibition by WIN-2. Conversely, carbachol decreased I M in the presence of SR1, indicating that cannabinoid and muscarinic receptor agonists independently decrease I M .
Postsynaptic actions of cannabinoids
The cannabinoid modulation of persistent conductances has not been investigated in brain neurons, precluding an adequate comparison with the present effect. In cultured hippocampal neurons, cannabinoids augment the transient K ϩ I A and may therefore modulate the excitatory synaptic input (Deadwyler et al., 1995) . Although this conductance does not readily influence neuronal activity, its augmentation denotes an inhibitory action of cannabinoids. Experiments conducted in non-neuronal expression systems showed that cannabinoids increased an inwardly rectifying K ϩ conductance (Henry and Chavkin, 1995; Mackie et al., 1995) . The augmentation of such conductance generates a small outward current to inhibit neuronal activity, in contrast to the present results that point to increased excitability. Such differences can be explained by the use of totally different preparations, native brain slices versus non-neuronal systems expressing CB1 receptors. As well, the lack of effect of cannabinoids on I M and I A in ganglion neurons transiently expressing CB1 receptors may be because of an ineffective coupling of the adequate second messenger systems (Pan et al., 1996) .
The identification of the intracellular mechanisms of I M inhibition remains under intense investigation. A rise of intracellular Ca 2ϩ levels may play a key role in the decrease of I M by various transmitters (for review, see Marrion, 1997) . Cannabinoids can increase intracellular Ca 2ϩ levels via phospholipase C in cell lines (Sugiara et al., 1997) . Cannabinoids also enhance the depolarization-induced increase of intracellular Ca 2ϩ by a mechanism involving phospholipase C and Ca 2ϩ release from inositol triphosphate-sensitive Ca 2ϩ stores in cerebellar neurons (Netzeband et al., 1999) . Interestingly, a recent study showed that bradykinin inhibits I M in ganglion neurons via phospholipase C and Ca 2ϩ release from inositol triphosphate-sensitive Ca 2ϩ stores (Cruzblanca et al., 1998) . Such a mechanism could be . Carbachol (CCh, 5 M) had no effect on I M because of blockade of muscarinic receptors, but addition of 2 M W I N-2 in the continued presence of atropine decreased I M . RM P was Ϫ67 mV. B, Average I M amplitude on five cells exposed to 1 M atropine, followed by 2 M WIN-2. The cannabinoid-induced I M decrease was unaffected by the muscarinic receptor antagonist. C, I M relaxation elicited with a 10 mV hyperpolarizing step (V H of Ϫ44 mV) in the presence of SR1. W I N-2 had no effect on I M because of blockade of CB1 receptors, but 5 M CCh decreased I M (washout performed in atropine). RM P was Ϫ69 mV. involved in the cannabinoid inhibition of I M in CA1 pyramidal neurons in which an increase in intracellular concentrations of inositol triphosphate reportedly decrease I M (Dutar and Nicoll, 1988) .
Cannabinoids and eicosanoids have opposite effects
Arachidonic acid and its metabolites, the eicosanoids, are potent signaling molecules implicated in several forms of neuromodulation (Meves, 1994; Piomelli, 1994) . Although arachidonic acid is produced upon degradation of anandamide and 2-arachidonylglycerol (Mechoulam et al., 1998a) , the fatty acid and its lipoxygenase metabolites augment I M in CA1 pyramidal neurons (Schweitzer et al., 1990) , an effect opposite to those of cannabinoids. Interestingly, arachidonic acid also decreases the hippocampal I A (Keros and McBain, 1997) , whereas cannabinoids increase it (Deadw yler et al., 1993) . Furthermore, cannabinoids prevent hippocampal long-term potentiation (Collins et al., 1994; Stella et al., 1997) , whereas arachidonic acid elicits this phenomenon (Williams et al., 1989) . Thus, cannabinoids and eicosanoids act on similar targets in hippocampus but in an opposite direction. The arachidonic acid produced upon endocannabinoid degradation has to be rapidly removed to prevent f urther biological effects. Indeed, very little arachidonic acid resulting from endocannabinoid hydrolysis is detected using cellular assays, because the fatty acid appears to be immediately reincorporated into membrane phospholipids (Mechoulam et al., 1998a) . The I M decrease via arachidonic acid activation of protein kinase C reported in cultured cells (Schmitt and Meves, 1993) is also an unlikely mechanism, especially because a recent study indicates that stimulation of protein kinase C phosphorylates CB1 receptors and prevents cannabinoid actions (Garcia et al., 1998) . Evidently, the eicosanoids do not mediate cannabinoid effects. Still, the fact that these two closely related families of lipidic mediators have opposite effects is puzzling.
Functional implications
Because I M is a persistent current active near the threshold for action potential initiation, it has a major influence on neuronal excitability and responsiveness to synaptic inputs (Marrion, 1997) . The primary role of I M is to clamp the membrane potential near rest. When depolarizing events occur, I M activates to hyperpolarize the membrane back toward resting potential and prevents excessive depolarizations. Thus, I M participates in the mechanism of spike frequency adaptation to slow the firing of action potentials (Aiken et al., 1995) and also plays a major role in the termination of bursting activity in CA1 neurons (Azouz et al., 1996) . By reducing I M , cannabinoids diminish the ability of neurons to counteract depolarizations, favoring increased firing of action potentials and prolonged bursting.
Interestingly, cannabinoids reinforce bursting activity in CA1 hippocampus (Xue et al., 1993) and increase neuronal firing rate and bursting activity in the ventral tegmentum and substantia nigra pars compacta in vivo (French et al., 1997) , an effect consistent with I M inhibition. An alteration of I M could also be involved in the dual effects of cannabinoids on neurons of the solitary tract nucleus (Himmi et al., 1998) . The present results indicate that, in addition to presynaptic disinhibitory effects associated with decreased GABAergic transmission (Miller and Walker, 1995; Chan and Yung, 1998; Szabo et al., 1998) , cannabinoids may also directly increase neuronal activity via postsynaptic actions. It should be noted, however, that hippocampal pyramidal neurons reportedly possess few CB1 receptors (Tsou et al., 1998) , and an indirect effect is always possible despite the blockade of neurotransmission by tetrodotoxin.
Recent reports have attributed the occurrence of an epileptic syndrome to mutations of the K ϩ channel genes KCNQ2 and KCNQ3 (Biervert et al., 1998; Charlier et al., 1998) . Further work demonstrated that the combination of KCNQ2 and KCNQ3 subunits, highly expressed in hippocampus, form native M-channels (Wang et al., 1998) . These data strongly implicate I M in the control of seizure. Cannabinoid research performed before the identification of specific receptors showed that ⌬ 9 -tetrahydrocannabinol has both convulsant and anticonvulsant effects (for review, see Martin, 1986) . Although the mechanisms implicated in these actions were not determined, the anticonvulsant effect could be possibly attributed to the cannabinoid inhibition of glutamate release (Ameri, 1999) . On the other hand, and consistent with the alteration of M-channel expression in some form of epilepsy, the cannabinoid inhibition of I M could play a role in the reported convulsant action.
Conclusion
The activation of CB1 receptors postsynaptically decreases I M in CA1 pyramidal neurons. This action will diminish the ability of neurons to counteract depolarizing events and may play an important role in response to hyperexcitability and bursting in hippocampus. Cannabinoids can therefore increase neuronal excitability by altering I M but can also decrease hippocampal activity by inhibiting neurotransmitter release and synaptic plasticity. Surprisingly, cannabinoids and eicosanoids have opposite effects on hippocampal electrophysiology.
